Skip to Content


In the US, Boceprevir (boceprevir systemic) is a member of the drug class protease inhibitors and is used to treat Hepatitis C.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antiviral agent

Antiviral agent: Treatment of hepatitis C

Chemical Names

(1R,2S,5S)-N-[(2Ξ)-4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl]-3-{(2S)-2-[(tert-butylcarbamoyl)amino]-3,3-dimetylbutanoyl}-6,6-dimetyl-3-azabicyclo[3.1.0]hexane-2-carboxamide (WHO)

3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[3-amino-1-(cyclobutylmetyl)-2,3-dioxopropyl]-3-[(2S)-2-[[[(1,1-dimetyletyl)amino]carbonyl]amino]-3,3-dimetyl-1-oxobutyl]-6,6- dimetyl-, (1R,2S,5S)- (USAN)

Foreign Names

  • Boceprevirum (Latin)
  • Boceprevir (German)
  • Bocéprévir (French)
  • Boceprevir (Spanish)

Generic Names

  • Boceprevir (OS: USAN, BAN)
  • EBP 520 (IS)
  • SCH 503034 (IS)
  • UNII-89BT58KELH (IS)

Brand Names

  • Victrelis
    Haemato Pharm, Austria; Merck Sharp & Dohme, Austria; Merck Sharp & Dohme, Australia; Merck Sharp & Dohme, Bosnia & Herzegowina; Merck Sharp & Dohme, Chile; Merck Sharp & Dohme, United Kingdom; Merck Sharp & Dohme, Greece; Merck Sharp & Dohme, Hong Kong; Merck Sharp & Dohme, Croatia (Hrvatska); Merck Sharp & Dohme, Iceland; Merck Sharp & Dohme, Malaysia; Merck Sharp & Dohme, New Zealand; Merck Sharp & Dohme, Slovenia; MSD, Norway; MSD, Sweden; MSD, Thailand; MSD Belgium, Belgium; MSD Italia, Italy; MSD Merck Sharp & Dohme, Germany; MSD Merck Sharp & Dohme, Turkey; MSD Pharma, Hungary; Orifarm, Norway; Schering-Plough, Georgia; Schering-Plough, Indonesia; Schering-Plough, Slovakia; Merck, Canada; Merck Sharp & Dohme, Colombia; Merck Sharp & Dohme, Spain; Merck Sharp & Dohme, Israel; Merck Sharp & Dohme, Mexico; Merck Sharp & Dohme, Poland; Merck Sharp & Dohme, Portugal; Merck Sharp & Dohme, Romania; Merck Sharp & Dohme, United States; MSD, Argentina; MSD, Switzerland; MSD, Denmark; MSD, Finland; MSD, Ireland
  • Victrelis Triple (Boceprevir and Ribavirin, + Peginterferon alfa-2b)
    Merck, Canada


BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.